title: An overview of treatment of overactive bladder syndrome in women.
abstract: Overactive bladder syndrome (OAB) is a common, often under-reported and under-treated condition that significantly affects the quality of life (QoL) of the sufferer and is associated with enormous related costs. Treatments options for OAB include lifestyle modifications, behavioural therapy, pharmacotherapy, neuromodulation, Botulinum toxin therapy and surgical interventions. For this paper, the Embase, Cochrane and Medline databases were searched for studies relating to the treatment options for OAB with (urge urinary incontinence) UUI from 1975 to 2010. Studies were also obtained from references of published reviews. Search terms used for retrieval were: overactive bladder syndrome, urge urinary incontinence, anticholinergics, Botulinum toxin A, sacral neuromodulation and clam bladder augmentation. The aim of this paper is to provide an overview of the treatment options currently available for women with OAB.
authors.affiliation: Department of Obstetrics and Gynaecology, St Mary's Hospital, Newport, Isle of Wight, UK. drallahdin@hotmail.co.uk
authors.forename: S
authors.initials: S
authors.lastname: Allahdin
authors.forename: N
authors.initials: N
authors.lastname: Oo
mesh_terms: D001521:Behavior Therapy; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008019:Life Style; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009465:Neuromuscular Agents / Q000627:therapeutic use; D056887:Pelvic Organ Prolapse / Q000150:complications / Q000601:surgery; D004561:Transcutaneous Electric Nerve Stimulation; D001743:Urinary Bladder / Q000601:surgery; D053201:Urinary Bladder, Overactive / Q000150:complications / Q000628:therapy*; D053202:Urinary Incontinence, Urge / Q000150:complications
chemical_list: D018727:Muscarinic Antagonists; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A